[ad_1]
Rome, March 8, 2021 – Green light to AstraZeneca vaccine also for people over 65. This is what the circular of the Ministry of Health, signed by the General Director of Prevention, Gianni rezzaand published today. Therefore, the anti-Covid drug can be administered to all subjects over 18 years of age, with the exception of patients identified as “extremely vulnerable due to immunodeficiency conditions, primary or secondary to pharmacological treatments or concomitant diseases, which increases considerably the risk developing fatal forms of Covid-19 “.
Coronavirus Italy, the newsletter for March 8
AstraZeneca: 684,000 doses have arrived
Meanwhile, tonight, at 8:45 p.m., 684,000 doses of the AstraZeneca vaccine arrived at the Pratica di Mare airport, the national defense vaccination center. After the subdivision by the personnel of the Ministry of Health, as of tomorrow the distribution in the different Regions with the Defense means will begin as part of “Operation Eos”.
That is why even those over 65
The decision follows a favorable opinion from Higher Health Council: “More scientific evidence available – says the ministerial circular – not only confirms the profile of safety favorable in relation to the vaccine in question, but indicate that, even in subjects over 65 years of age, the administration of the AstraZeneca vaccine is capable of inducing significant protection from both the development of pathology induced by Sars-CoV-2, as well as from serious or even fatal forms of Covid-19 “. Based on these considerations, therefore,” also in a public health perspective characterized by limited availability of vaccine doses and given the need to protect the groups of subjects most exposed to the risk of developing serious pathologies or even fatal forms of Covid-19 – concludes the circular -, the working group on Sars-CoV-2 of the Higher Health Council has expressed a favorable opinion that the AstraZeneca vaccine can also be administered to subjects over 65 years of age. “
She was the president of the European Commission, Ursula von der Leyen, to attack the pharmaceutical company, warning that AstraZeneca has so far turned itself over to the EU “less than 10% of the agreed amount“on Covid-19 vaccines. In a meeting with some international media, von der Leyen warned that” there will be no hesitation in to intervene again if AstraZeneca does not increase production and supply for the EU. “They cannot explain why they do not deliver to the EU – he added -. But suddenly they found vaccines to send to Australia,” he said in reference to the batch of 250 thousand doses. blocked by Italy. In the meantime, therefore, the EU leader concluded, the European Union will continue bulk exports of AstraZeneca vaccines, until the company delivers sufficient doses to the EU: “AstraZeneca must increase its efforts. Otherwise, we cannot allow exports.”
Who gets the vaccine? Chaos of the charts
Von der Leyen: “100 million doses per month since April”
L ‘Italy It tries, at least it seems, to speed up vaccinations, given the steep resumption of the epidemic curve and the new hardening that comes from the Draghi government to stop the wave of infections. Yesterday the Minister of Health, Roberto Speranza, he assured that “As of April 1, the second quarter begins in which we expect the arrival of more than 50 million doses, and our goal is to reach at least half of the population “, to reach “by summer“make sure of”everybody Italians who want it can be vaccine“And today thereas President of the EU Commission, Ursula von der Leyen, said the number of vaccine doses available in the EU is expected to reach 100 million per month as of April. “From April – he said in an interview with the German newspapers Stuttgarter Zeitung and Stuttgarter Nachrichten – the quantities could be doubled again according to the plans of the producers, also because more vaccines are about to be approved.” He then added that he expects “an average of about 100 million doses per month in the second quarter, for a total of 300 million at the end of June“.
Ema: guidelines for adapted vaccines
“L ‘Mother has already published guidelines to expedite the approval of adapted vaccines in case of new variants. We will adopt it at boarding school on March 11, ”said the president of the European Commission, Ursula Von der Leyen.
First agreement for the production of Sputnik in Italy
The first agreement for theto the production of the Sputnik vaccine in Italyand the first of its kind in Europe: it was signed by the sovereign wealth fund of the Russian state, which holds the patent for the vaccine, the Russian Fund for Direct Investment and the Italian-Swiss pharmaceutical company Adienne Pharma and biotechnology, which will produce the vaccine in two plants, in Lombardy and central Italy, and says that it is ready to supply 10 million doses from July 2021 to January 2022. This was announced by the Italo-Russian Chamber of Commerce, which explains how “once the vaccine is approved by the EMA, the doses produced they will be distributed in their entirety throughout the Italian territory “.
“The association will allow to start production from the month of July 2021 – reads a press release from the Chamber of Commerce – the innovative production process will help create new jobs and allow Italy to control the entire production process of the preparation. This will allow the production of 10 million doses by the end of the year“.
“The Russian authorities are working on more than 20 collaborative projects in Europe and the Sputnik V vaccine has already been registered in more than 45 nations in the world“, explains the Italo-Russian Chamber of Commerce.” The meetings, promoted by the Italo-Russian Chamber of Commerce, aimed to identify some strategic partners in Italy to prepare the production of the Sputnik V vaccine in the Italian territory, using the Italian knowledge and excellence of the Italian pharmaceutical industry to satisfy the growing demand for doses of vaccine preparations “.” In particular in the last months of 2020 – he concludes -, the Italian associate company Adienne Srl, part of the multinational Adienne Pharma & Biotech founded and chaired by Antonio Francesco Di Naro, with the support of the Italo-Russian Chamber of Commerce, has promoted a strategic agreement for the local production of the Russian vaccine Sputnik V “.
© All rights reserved
